UT Health Newsroom: Barshop Institute’s Palavicini attracts early scientist award
Original story: UT Health San Antonio Newsroom
American Federation for Aging Research grant allows exploration of signaling molecules toxic in Alzheimer’s, diabetes, aging
The American Federation for Aging Research (AFAR) selected Juan Pablo Palavicini, PhD, an early career scientist at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), to receive the 2022 Glenn Foundation for Medical Research and AFAR Grants for Junior Faculty.
Palavicini is an investigator in the Sam and Ann Barshop Institute for Longevity and Aging Studies and an assistant professor of medicine (diabetes division) in the Joe R. and Teresa Lozano Long School of Medicine, all part of UT Health San Antonio. His research interests include studying the role of ceramides, which are important signaling molecules that in excess become toxic in Alzheimer’s disease, diabetes and aging.
His Glenn Foundation/AFAR grant of $124,842 will fund research of a mouse population that has significantly less ceramides and lives longer.